• LAST PRICE
    11.9350
  • TODAY'S CHANGE (%)
    Trending Up0.4350 (3.7826%)
  • Bid / Lots
    11.5000/ 1
  • Ask / Lots
    12.1900/ 10
  • Open / Previous Close
    11.5000 / 11.5000
  • Day Range
    Low 11.2700
    High 12.2100
  • 52 Week Range
    Low 2.8400
    High 14.8500
  • Volume
    138,336
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 11.5
TimeVolumeBMEA
09:32 ET1047311.27
09:34 ET10011.31
09:41 ET20011.69
09:54 ET20011.68
09:56 ET10011.56
09:59 ET30011.67
10:12 ET15611.66
10:15 ET10011.68
10:19 ET40011.83
10:21 ET90011.83
10:24 ET10511.8693
10:35 ET10011.85
11:13 ET19511.84
11:18 ET30011.825
11:40 ET90011.835
11:44 ET90011.835
11:45 ET232711.89
11:47 ET210011.86
11:49 ET229111.82
11:51 ET120011.945
11:54 ET712112
11:56 ET400311.9
11:58 ET100011.815
12:05 ET40011.83
12:07 ET20011.82
12:14 ET70011.9
12:16 ET10011.9
12:18 ET3955912.075
12:20 ET1161111.7394
12:21 ET50011.79
12:23 ET90011.8
12:27 ET62511.82
12:30 ET20011.82
12:34 ET20011.8
12:36 ET20611.8599
12:38 ET30011.86
12:52 ET30011.895
12:59 ET102011.81
01:30 ET50011.77
01:32 ET61811.77
01:33 ET100011.76
01:44 ET70511.74
01:48 ET40011.8
01:50 ET72011.85
01:51 ET39111.875
01:53 ET10011.875
01:57 ET227811.85
02:02 ET30011.82
02:04 ET89811.81
02:06 ET10011.84
02:08 ET10011.825
02:09 ET30011.82
02:24 ET10011.82
02:27 ET20011.8
02:29 ET12311.82
02:36 ET30011.815
02:42 ET10011.79
02:47 ET10011.82
02:49 ET10011.82
02:54 ET162411.8
02:56 ET40011.805
03:00 ET10011.9
03:02 ET31711.91
03:03 ET318911.855
03:05 ET20011.855
03:07 ET10011.86
03:12 ET20011.895
03:18 ET14611.9
03:38 ET10011.88
03:39 ET20011.885
03:41 ET10011.895
03:43 ET40011.87
03:45 ET10211.8679
03:50 ET40011.83
03:52 ET20011.91
03:54 ET10011.895
03:56 ET117411.93
03:57 ET193011.93
03:59 ET186611.935
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBMEA
Biomea Fusion Inc
349.1M
-5.7x
---
United StatesCBAY
Cymabay Therapeutics Inc
352.3M
-3.0x
---
United StatesPHAT
Phathom Pharmaceuticals Inc
354.1M
-2.2x
---
United StatesTHRX
Theseus Pharmaceuticals Inc
324.3M
-9.3x
---
United StatesRLYB
Rallybio Corp
344.8M
-6.4x
---
United StatesNAUT
Nautilus Biotechnology Inc
354.0M
-5.8x
---
As of 2022-08-13

Company Information

Biomea Fusion, Inc. is a preclinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The Company has built FUSION System discovery platform to advance a pipeline of irreversible small molecule product candidates. The Company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The Company is developing BMF-219 for the treatment of liquid and solid tumors that are dependent on menin, including leukemias containing the mixed lineage leukemia (MLL) fusion protein. The Company is also advancing other preclinical irreversible programs for the treatment of select cancers.

Contact Information

Headquarters
900 Middlefield Road, 4Th FloorREDWOOD CITY, CA, United States 94063
Phone
650-980-9099
Fax
302-655-5049

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Thomas Butler
President, Co-Founder, Chief Operating Officer, Director
Rainer Erdtmann
Chief Financial Officer, Principal Accounting Officer
Franco Valle
Independent Director
Eric Aguiar
Independent Director
Bihua Chen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$349.1M
Revenue (TTM)
$0.00
Shares Outstanding
29.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.09
Book Value
$6.14
P/E Ratio
-5.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.